These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8510226)

  • 21. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.
    Yanagi Y; Maekawa R; Cook T; Kanagawa O; Oldstone MB
    J Virol; 1990 Dec; 64(12):5919-26. PubMed ID: 1700830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo.
    Rall GF; Mucke L; Oldstone MB
    J Exp Med; 1995 Nov; 182(5):1201-12. PubMed ID: 7595191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of protective immunity using minigenes.
    Whitton JL
    Ann N Y Acad Sci; 1994 Aug; 730():107-17. PubMed ID: 7521600
    [No Abstract]   [Full Text] [Related]  

  • 24. Single-epitope DNA vaccination prevents exhaustion and facilitates a broad antiviral CD8+ T cell response during chronic viral infection.
    Bartholdy C; Stryhn A; Christensen JP; Thomsen AR
    J Immunol; 2004 Nov; 173(10):6284-93. PubMed ID: 15528367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.
    Oehen S; Waldner H; Kündig TM; Hengartner H; Zinkernagel RM
    J Exp Med; 1992 Nov; 176(5):1273-81. PubMed ID: 1402673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cells efficiently induce protective antiviral immunity.
    Ludewig B; Ehl S; Karrer U; Odermatt B; Hengartner H; Zinkernagel RM
    J Virol; 1998 May; 72(5):3812-8. PubMed ID: 9557664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell memory. Long-term persistence of virus-specific cytotoxic T cells.
    Jamieson BD; Ahmed R
    J Exp Med; 1989 Jun; 169(6):1993-2005. PubMed ID: 2471771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.
    Aichele P; Hengartner H; Zinkernagel RM; Schulz M
    J Exp Med; 1990 May; 171(5):1815-20. PubMed ID: 1692084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of CCR7 on priming and distribution of antiviral effector and memory CTL.
    Junt T; Scandella E; Förster R; Krebs P; Krautwald S; Lipp M; Hengartner H; Ludewig B
    J Immunol; 2004 Dec; 173(11):6684-93. PubMed ID: 15557160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence.
    Salvato M; Borrow P; Shimomaye E; Oldstone MB
    J Virol; 1991 Apr; 65(4):1863-9. PubMed ID: 1840619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"?
    Bachmann MF; Kündig TM; Hengartner H; Zinkernagel RM
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):640-5. PubMed ID: 9012837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA vaccination against persistent viral infection.
    Martins LP; Lau LL; Asano MS; Ahmed R
    J Virol; 1995 Apr; 69(4):2574-82. PubMed ID: 7884908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection.
    Cole GA; Hogg TL; Coppola MA; Woodland DL
    J Immunol; 1997 May; 158(9):4301-9. PubMed ID: 9126992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection.
    Holst PJ; Jensen BA; Ragonnaud E; Thomsen AR; Christensen JP
    PLoS One; 2015; 10(2):e0117242. PubMed ID: 25679375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination.
    Tan JT; Whitmire JK; Murali-Krishna K; Ahmed R; Altman JD; Mittler RS; Sette A; Pearson TC; Larsen CP
    J Immunol; 2000 Mar; 164(5):2320-5. PubMed ID: 10679066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination for disease.
    Oehen S; Hengartner H; Zinkernagel RM
    Science; 1991 Jan; 251(4990):195-8. PubMed ID: 1824801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphism of cytotoxic T-lymphocyte clones that recognize a defined nine-amino-acid immunodominant domain of lymphocytic choriomeningitis virus glycoprotein.
    Joly E; Salvato M; Whitton JL; Oldstone MB
    J Virol; 1989 May; 63(5):1845-51. PubMed ID: 2467990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope.
    Shams H; Poblete F; Rüssmann H; Galán JE; Donis RO
    Vaccine; 2001 Nov; 20(3-4):577-85. PubMed ID: 11672924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficiency and effectiveness of cloned virus-specific cytotoxic T lymphocytes in vivo.
    Klavinskis LS; Tishon A; Oldstone MB
    J Immunol; 1989 Sep; 143(6):2013-6. PubMed ID: 2476492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.